THYMOGLOBULINE for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 40 adverse event reports in the FDA FAERS database where THYMOGLOBULINE was used for Bone marrow conditioning regimen.
Most Reported Side Effects for THYMOGLOBULINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 26 | 23.9% | 5 | 21 |
| Pyrexia | 13 | 11.9% | 6 | 9 |
| Acute graft versus host disease | 10 | 9.2% | 6 | 2 |
| Cytomegalovirus infection | 10 | 9.2% | 4 | 6 |
| Pneumonia | 10 | 9.2% | 7 | 5 |
| Cytomegalovirus viraemia | 9 | 8.3% | 4 | 7 |
| Post transplant lymphoproliferative disorder | 9 | 8.3% | 7 | 2 |
| Renal impairment | 6 | 5.5% | 3 | 5 |
| Thrombotic microangiopathy | 6 | 5.5% | 5 | 5 |
| Neutrophil count decreased | 5 | 4.6% | 2 | 4 |
| Staphylococcal sepsis | 5 | 4.6% | 3 | 4 |
Other Indications for THYMOGLOBULINE
Aplastic anaemia (37)
Acute graft versus host disease (8)
Kidney transplant rejection (5)
Product used for unknown indication (5)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)